Sophiris Bio to Present Plans For Enlarged Prostate Treatment - Presented by: The Aol. On Network

Sophiris Bio (SPHS) will present at the Stifel Healthcare Conference on September 12th to discuss the company's targeted treatment of benigh prostatic hyperplasia. The conference comes just a few weeks after the company announced it had closed its public offering to raise $65 million.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.385 0.06 ▼ 0.36%
FB $ 66.40 1.53 ▲ 2.35%
MTG $ 8.4001 0.84 ▼ 9.09%
GE $ 26.51 0.31 ▲ 1.18%
AAPL $ 95.02 0.02 ▼ 0.02%
WFC $ 51.51 0.30 ▼ 0.58%
GNW $ 16.655 0.41 ▼ 2.37%
S $ 8.46 0.21 ▲ 2.55%

As of 7/11/2014, 03:27 PM
More Most Active